Atul Aggarwal - Concepedia

Author

Atul Aggarwal

University of Vermont

Also Known As

A Aggarwal, A. Aggarwal, Aggarwal A, Arushika Aggarwal, Atul Aggarwal

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of Vermont United States Military Academy Comprehensive Cardiovascular Baylor College of Medicine Denver VA Medical Center

About

Atul Aggarwal is an author at University of Vermont specializing in medicine, cardiovascular disease, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	880
2	Public Health	3	3	164
3	Social Sciences	1	1	12
4	Anatomy	1	1	10
5	Diabetes	1	1	28

Atul Aggarwal

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Incidence and Outcomes of No-Reflow Phenomenon During Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction Robert W. Harrison, Atul Aggarwal, Fang‐Shu Ou, The American Journal of Cardiology Percutaneous Coronary InterventionCardiovascular DiseaseOutcomes ResearchAcute Myocardial InfarctionNo-reflow Phenomenon	2012	243
Incidence and Predictors of Stroke Associated With Percutaneous Coronary Intervention Atul Aggarwal, David Dai, John S. Rumsfeld, The American Journal of Cardiology ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseHealth PolicyIschemic Stroke	2009	106
Suboptimal early inhibition of platelets by treatment with tirofiban and implications for coronary interventions Samer Kabbani, Atul Aggarwal, Edward F. Terrien, The American Journal of Cardiology ThrombopoiesisPercutaneous Coronary InterventionThrombosisCardiovascular DiseaseBlood Platelet	2002	94
Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation Atul Aggarwal, Yongfei Wang, John S. Rumsfeld, Heart Rhythm HemodialysisUrologyImplantable Cardioverter-defibrillator ImplantationMedicineKidney Failure	2009	73
Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: A potential contributor to cardiovascular risk Atul Aggarwal, Samer Kabbani, Jeffery M. Rimmer, American Journal of Kidney Diseases End-stage Renal DiseaseThrombosisHemodialysisThrombopoiesisCardiovascular Disease	2002	73
Enhanced early inhibition of platelet aggregation with an increased bolus of tirofiban David J. Schneider, Howard C. Herrmann, Nasser Lakkis, The American Journal of Cardiology ThrombopoiesisThrombosisBlood PlateletMedicinePlatelet Aggregation	2002	71
Increased concentrations of tirofiban in blood and their correlation with inhibition of platelet aggregation after greater bolus doses of tirofiban David J. Schneider, Howard C. Herrmann, Nasser Lakkis, The American Journal of Cardiology ThrombopoiesisThrombosisCardiovascular DiseaseBlood PlateletMedicine	2003	70
Decreased Platelet Reactivity in Blood Anticoagulated with Bivalirudin or Enoxaparin Compared with Unfractionated Heparin: Implications for Coronary Intervention Atul Aggarwal, Burton E. Sobel, David J. Schneider Journal of Thrombosis and Thrombolysis	2002	46
Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques Atul Aggarwal, David J. Schneider, Edward F. Terrien, The American Journal of Cardiology InflammationVascular DiseaseCardiovascular DiseaseInterleukin-1 Receptor AntagonistImmunology	2003	42
Increase in Interleukin-6 in the First Hour after Coronary Stenting: An Early Marker of the Inflammatory Response Atul Aggarwal, David J. Schneider, Edward F. Terrien, Journal of Thrombosis and Thrombolysis	2003	39

Page 1